1Sundstrom S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.J Clin Oncol, 2002, 20(24): 4665-4672.
2Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited-stage small-cell lung cancer.J Clin Oncol, 1996, 14(3): 821-828.
3Jara c, Gomez-Aldaravi JL, Tirado R, et al. Small-cell lung cancer in the elderly-is age of patient a relevant factor? Acta Oncol, 1999, 38(6): 781-786.
4Noguchi T, Mochizuki H, Yamazaki M, et al. A retrospective analysis of clinical outcomes of patients older than or equal to 80 years with small cell lung cancer.J Thora Oncol, 2010, 5(7): 1081-1087.
5Caprario LC, Kent DM, Trikalinos TA, et al. Determinants of chemotherapy administration and effects of chemotherapy on survival in elderly patients with small cell lung cancer (SCLC): A SEER-medicare analysis. J Clin Oncol, 2011, 29(15 S): 7083 [abstract].
6Kim YH, Mishima M. Second-line chemotherapy for small-cell lung cancer (SCLC). Cancer Treat Rev, 2011, 37(2): 143-150.
7Von Pawel J, Gatzemeier U, PujolJL, et al. Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer.J Clin Oncol, 2001, 19(6): 1743-1749.
8Eckardt JR, von Pawel J, Pujol JL, et al. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. J Clin Oncol, 2007, 25 (15 ) : 2086-2092.
9O'Brien ME, Ciuleanu TE, Tsekov H, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.J Clin Oncol, 2006, 24(34): 5441-5447.
10von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol, 1999, 17(2): 658-667.
6Watkins J M, Wahlqtaist A E, Shirai, - K, et al. Factors as- sociated with severe acute esophagitis from hyperfraetionated radiotherapy with concurrent chemotherapy for limited- stage small- cell lung cancer [ J ]. Int J Radiat Oncol Biol Phys, 2009, 74(4): 1108.
7Uno T, Sumi M, Ishihara Y, Numasaki H, et al. Changes in patterns of care for limited - stage small - cell lung cancer: results of the 99 - 01 patterns of care study - anation- widesurvey in Japan. Japanese PCS Working Subgroup of Lung Cancer[J]. Int J Radiat Oncol Biol Phys, 2008, 71 (2) : 414.
8Le Q T, Moon J, Redman M, et al. Phase II study of tira-pazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited - stage small - cell lung cancer: SWOG 0222[J]. J Clin Oncol, 2009, 27(18): 3014.
